top of page
PATHOS TSUTSUMI PROJECT
”Tsutsumi
Pathology Library”
Yutaka Tsutsumi, M.D.
Pr.3 Cytology (general) (86 cases)
cyto-1-Cx_cyto-gyne (1-24)_uterine cervix_45F_Pap_NILM: squamous metaplasia
cyto-2-Cx_cyto-gyne (1-24)_uterine cervix_60'sF_Pap_NILM: senile colpitis
cyto-2-2-Cx_cyto-gyne (1-24)_uterine cervix_agedF_Pap/HE/IHC_NILM: senile colpitis: senile colpitis or dysplasia？the usefulness of p16 immunostaining in post-menopausal cytology
cyto-3-Cx_cyto-gyne (1-24)_uterine cervix_40'sF_Pap_NILM: reactive irradiation change-1
cyto-4-Cx_cyto-gyne (1-24)_uterine cervix_40'sF_Pap_NILM: reactive irradiation change-2
cyto-5-Cx_cyto-gyne (1-24)_uterine cervix_28F_Pap (LBC)_NILM: Gardnerella infection
cyto-6-Cx_cyto-gyne (1-24)_uterine cervix_23F_Pap (LBC)_NILM: herpes simplex virus infection
cyto-7-Cx_cyto-gyne (1-24)_uterine cervix_30'sF_Pap_NILM: Trichomonas vaginalis infection
cyto-8-Cx_cyto-gyne (1-24)_uterine cervix_21F_Pap_NILM: Trichomonas vaginalis infection
cyto-9-Cx_cyto-gyne (1-24)_uterine cervix_41F_Pap (LBC)_LSIL: mild dysplasia
cyto-10-Cx_cyto-gyne (1-24)_uterine cervix_45F_Pap (LBC)_LSIL: mild dysplasia
cyto-11-Cx_cyto-gyne (1-24)_uterine cervix_32F_Pap_LSIL: mild dysplasia
cyto-12-Cx_cyto-gyne (1-24)_uterine cervix_35F_Pap (LBC)_HSIL: moderate dysplasia
cyto-13-Cx_cyto-gyne (1-24)_uterine cervix_44F_Pap (LBC)_HSIL: moderate dysplasia
cyto-14-Cx_cyto-gyne (1-24)_uterine cervix_86F_Pap (LBC)_HSIL: severe dysplasia
cyto-15-Cx_cyto-gyne (1-24)_uterine cervix_30F_Pap (LBC)_HSIL: severe dysplasia
cyto-16-Cx_cyto-gyne (1-24)_uterine cervix_40F_Pap_HSIL: severe dysplasia
cyto-17-Cx_cyto-gyne (1-24)_uterine cervix_40F_Pap (LBC)_HSIL: CIS
cyto-18-Cx_cyto-gyne (1-24)_uterine cervix_44F_Pap (LBC)_SCC (squamous cell carcinoma)
cyto-19-Cx_cyto-gyne (1-24)_uterine cervix_54F_Pap_SCC (squamous cell carcinoma)-1
cyto-20-Cx_cyto-gyne (1-24)_uterine cervix_54F_Pap_SCC (squamous cell carcinoma)-2
cyto-21-Cx_cyto-gyne (1-24)_uterine cervix_46F_Pap_adenocarcinoma
cyto-22-Em_cyto-gyne (1-24)_endometrium_49F_Pap_proliferative phase endometrium
cyto-23-Em_cyto-gyne (1-24)_endometrium_37F_Pap_secretory phase endometrium
cyto-24-Em_cyto-gyne (1-24)_endometrium_63F_Pap_endometrioid adenocarcinoma
cyto-25-sputum_cyto-lung (25-31)_sputum_31F_Pap_adenocarcinoma
cyto-26-sputum_cyto-lung (25-31)_sputum_73M_Pap_adenocarcinoma
cyto-27-sputum_cyto-lung (25-31)_sputum_77M_Pap_squamous cell carcinoma
cyto-28-sputum_cyto-lung (25-31)_sputum_81M_Pap_squamous cell carcinoma
cyto-29-sputum_cyto-lung (25-31)_sputum_79M_Pap (LBC)_small cell carcinoma
cyto-30-sputum_cyto-lung (25-31)_sputum_79F_Pap_small cell carcinoma
cyto-31-sputum_cyto-lung (25-31)_bronchial lavage_61F_Pap_metastatic adenocarcinoma (breast cancer)
cyto-32-breast_cyto-FNA (32-35)_breast_82F_Pap_ductal carcinoma
cyto-33-breast_cyto-FNA (32-35)_breast_33F_Pap_ductal carcinoma
cyto-34-thyroid_cyto-FNA (32-35)_thyroid_53F_Pap_papillary carcinoma
cyto-35-1-thyroid_cyto-FNA (32-35)_thyroid_41F_Pap_papillary carcinoma-1
cyto-35-2-thyroid_cyto-FNA (32-35)_thyroid_41F_Giemsa_papillary carcinoma-2
cyto-36-1-PE_cyto-effusion (36-55)_pleural effusion_60'sM_Pap_reactive mesothelial cells-1
cyto-36-2-PE_cyto-effusion (36-55)_pleural effusion_60'sM_PAS_reactive mesothelial cells-2
cyto-37-1-PE_cyto-effusion (36-55)_pleural effusion_60'sM_Pap_reactive mesothelial cells-1
cyto-37-2-PE_cyto-effusion (36-55)_pleural effusion_60'sM_Giemsa_reactive mesothelial cells-2
cyto-38-1-PE_cyto-effusion (36-55)_pleural effusion_50'sM_Pap_malignant mesothelioma-1
cyto-38-2-PE_cyto-effusion (36-55)_pleural effusion_50'sM_Giemsa_malignant mesothelioma-2
cyto-38-3-PE_cyto-effusion (36-55)_pleural effusion_50'sM_PAS_malignant mesothelioma-3
cyto-39-PE_cyto-effusion (36-55)_pleural effusion_55M_Pap_malignant mesothelioma
cyto-40-PE_cyto-effusion (36-55)_pleural effusion_60'sM_Pap_malignant mesothelioma
cyto-41-1-PE_cyto-effusion (36-55)_pleural effusion_60'sM_Pap_malignant mesothelioma-1
cyto-41-2-PE_cyto-effusion (36-55)_pleural effusion_60'sM_Giemsa_malignant mesothelioma-2
cyto-42
cyto-43-PE_cyto-effusion (36-55)_pleural effusion_66M_Pap_poorly differentiated adenocarcinoma of lung
cyto-44-1-PE_cyto-effusion (36-55)_pleural effusion_50'sM_Pap_poorly differentiated adenocarcinoma of lung-1
cyto-44-2-PE_cyto-effusion (36-55)_pleural effusion_50'sM_Giemsa_poorly differentiated adenocarcinoma of lung-2
cyto-45-PE_cyto-effusion (36-55)_pleural effusion_70'sF_Pap_metastatic adenocarcinoma of lung
cyto-46-PE_cyto-effusion (36-55)_pleural effusion_71M_Pap_metastatic small cell carcinoma
cyto-47-1-PE_cyto-effusion (36-55)_pleural effusion_48F_Pap_metastatic breast carcinoma-1
cyto-47-2-PE_cyto-effusion (36-55)_pleural effusion (cell block)_48F_HE_metastatic breast carcinoma-2
cyto-48-PE_cyto-effusion (36-55)_pleural effusion_60'sF_Pap_metastatic thyroid carcinoma
cyto-49-ascites_cyto-effusion (36-55)_ascites_50'sM_Pap_malignant mesothelioma
cyto-50-1-ascites_cyto-effusion (36-55)_ascites_40'sF_Pap_metastatic ovarian carcinoma-1
cyto-50-2-ascites_cyto-effusion (36-55)_ascites_40'sF_PAS_metastatic ovarian carcinoma-2
cyto-51-ascites_cyto-effusion (36-55)_ascites_48F_Pap_metastatic ovarian carcinoma
cyto-52-1-ascites_cyto-effusion (36-55)_ascites_50F_Pap_metastatic ovarian carcinoma-1
cyto-52-2-ascites_cyto-effusion (36-55)_ascites_50F_PAS_metastatic ovarian carcinoma-2
cyto-53-1-ascites_cyto-effusion (36-55)_ascites_70'sF_Pap_metastatic gastric carcinoma-1
cyto-53-2-ascites_cyto-effusion (36-55)_ascites_70'sF_PAS_metastatic gastric carcinoma-2
cyto-54-ascites_cyto-effusion (36-55)_ascites_40'sM_Pap_metastatic pancreas carcinoma
cyto-55-1-ascites_cyto-effusion (36-55)_ascites_80'sF_Pap_invasion of multiple myeloma-1
cyto-55-2-ascites_cyto-effusion (36-55)_ascites_80'sF_Giemsa_invasion of multiple myeloma-2
cyto-56-CSF_cyto-brain (56-62)_cerebrospinal fluid_76M_Giemsa_adult T-cell leukemia
cyto-57-CSF_cyto-brain (56-62)_cerebrospinal fluid_4M_Giemsa_acute lymphoblastic leukemia L1)
cyto-58-CSF_cyto-brain (56-62)_cerebrospinal fluid_58F_Giemsa_metastatic signet ring cell carcinoma
cyto-59-brain_cyto-brain (56-62)_brain tumor touch_48F_Pap_astrocytoma, round cell type
cyto-60-brain_cyto-brain (56-62)_brain tumor touch_23F_Pap_anaplastic astrocytoma
cyto-61-brain_cyto-brain (56-62)_brain tumor touch_68F_Pap_meningioma
cyto-62-1-brain_cyto-brain (56-62)_brain tumor touch_43F_Pap_metastatic adenocarcinoma-1
cyto-62-2-brain_cyto-brain (56-62)_brain tumor touch_43F_Giemsa_metastatic adenocarcinoma-2
cyto-63-1-LN_cyto-hemato (63-86)_lymph node touch_42M_Pap_Hodgkin's lymphoma-1
cyto-63-2-LN_cyto-hemato (63-86)_lymph node touch_42M_Giemsa_Hodgkin's lymphoma-2
cyto-64-1-LN_cyto-hemato (63-86)_lymph node touch_71M_Pap_Diffuse large B-cell lymphoma-1
cyto-64-2-LN_cyto-hemato (63-86)_lymph node touch_71M_Giemsa_Diffuse large B-cell lymphoma-2
cyto-65-1-LN_cyto-hemato (63-86)_lymph node touch_21F_Pap_Ki-1 lymphoma-1
cyto-65-2-LN_cyto-hemato (63-86)_lymph node touch_21F_Giemsa_Ki-1 lymphoma-1
cyto-66-1-LN_cyto-hemato (63-86)_lymph node touch_22M_Pap_adult T-cell leukemia/lymphoma-1
cyto-66-2-LN_cyto-hemato (63-86)_lymph node touch_22M_Giemsa_adult T-cell leukemia/lymphoma-2
cyto-67-1-ovary_cyto-hemato (63-86)_ovary touch_23F_Pap_Burkitt lymphoma-1
cyto-67-2-ovary_cyto-hemato (63-86)_ovary touch_23F_Giemsa_Burkitt lymphoma-1
cyto-68-1-nose_cyto-hemato (63-86)_nasal mucosa touch_28M_Pap_nasal NK/T-cell lymphoma-1
cyto-68-2-nose_cyto-hemato (63-86)_nasal mucosa touch_28M_Giemsa_nasal NK/T-cell lymphoma-2
cyto-69-BM_cyto-hemato (63-86)_bone marrow_47M_Giemsa_acute promyelocytic leukemia (M3)
cyto-70-BM_cyto-hemato (63-86)_bone marrow_70M_Giemsa_acute monocytic leukemia (M5)
cyto-71-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_target cells
cyto-72-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_tear drop cells
cyto-73-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_acanthocytes
cyto-74-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_spherocytes
cyto-75-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_schistocytes
cyto-76-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_Howell-Jolly bodies
cyto-77-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_Pappenheimer bodies
cyto-78-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_Rouleaux formation
cyto-78-2-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_erythrocyte variations in May-Giemsa-stained smears
cyto-78-3-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_leukocyte variations in May-Giemsa-stained smears
cyto-78-4-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_thrombocyte variations in May-Giemsa-stained smears
cyto-79-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_leukemic transformation of lymphoma
cyto-80-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_adult T-cell lymphoma
cyto-81-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_chronic lymphocytic leukemia
cyto-81-2-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_lymphoid leukemias and multiple myeloma in May-Giemsa smears
cyto-82-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_chronic myeloid leukemia
cyto-82-2-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_myeloproliferative disorders in May-Giemsa smears
cyto-83-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_acute myeloblastic leukemia (M2)
cyto-84-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_acute promyelocytic leukemia (M3)
cyto-85-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_acute monocytic leukemia (M5)
cyto-86-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_acute monocytic leukemia (M5b)
cyto-86-2-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_acute myeloid leukemias in May-Giemsa smears
cyto-86-3-PB_cyto-hemato (63-86)_peripheral blood_-_EM_Electron micrographs of hematopoietic cells and their neoplasms
HOME
about us
How to login
PDF & free programs
Pr.3
Pr.7 Inf-cytology
PDF ( Pr.1~Pr.23) free Program
programs for members only
Pr.6
Pr.6 Inf-coc 1~48
Pr.6 Inf-act 125~134
Pr.6 Inf-myco 135~160
Pr.6 Inf-spiro 161~177
Pr.6 Inf-chlam 178~183
Pr.6 Inf-rick 184~192
Pr.6 Inf-virus 249~353
Pr.6 Inf-prot 354~386
Pr.6 Inf-nemet 387~421
Pr.6 Inf-tremat 422~445
Pr.6 Inf-cest 446~457
Pr.6 Inf-arthro 458~471
Pr.6 Inf-others 472~494
Pr.23 Sk-Ecz 1～12
Pr.23 Sk-Lick 13～17
Pr.23 Sk-Pso 18～24
Pr.23 Sk-EM 25～29
Pr.23 Sk-Lymph 30～40
Pr.23 Sk-Neutro 41～46
Pr.23 Sk-Eosino 47～54
Pr.23 Sk-GVHG 55～61
Pr.23 Sk-Bull 62～76
Pr.23 Sk-Granul 77～100
Pr.23 Sk-Vascul 101～132
Pr.23 Sk-Pannic 133～137
Pr.23 Sk-Epid 138～158
Pr.23 Sk-Prot 360～365
Pr.23 Sk-Helm 366～376
Pr.23 Sk-Arth 377～388
Pr.23 Nevus 389～416
Pr.23 Sk-BENeo 417～431
Pr.23 Sk-MENeo 432～465
Pr.23 Sk-AdNeo 466～517
Pr.23 Sk-LPD 518～549
Pr.23 Sk-Leukemia 550～553
Pr.23 Sk-MNENeo 626～651
Pr.23 Sk-Met 652~664
More
Use tab to navigate through the menu items.
bottom of page